Professional
Added to YB: 2025-04-25
Pitch date: 2025-03-31
WGS [neutral]
GeneDx Holdings Corp.
+72.17%
current return
Author Info
No bio for this author
Company Info
GeneDx Holdings Corp., a genomics company, provides genetic testing services. It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Market Cap
$3.7B
Pitch Price
$88.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
87.04
P/E
1.7K
EV/Sales
9.02
Sector
Health Care Providers and Services
Category
growth
Alger Small Cap Focus Fund Portfolio Holding: GeneDx Holdings Corp.
WGS (holding update): Genetic testing lab for rare diseases, mainly pediatric/NICU patients. Offers whole exome/genome sequencing, cancer screening, and individual gene tests. Stock up on strong Q4 results with robust customer demand. Management raised FY2025 revenue guidance above analyst estimates.
Read full article (1 min)